Carbon Dioxide Insufflation Colonoscopy in IBD Patients

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

64 participants

Study Classification

INTERVENTIONAL

Study Start Date

2015-10-31

Study Completion Date

2016-05-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Carbon dioxide insufflation during colonoscopy significantly reduces discomfort (pain, bloating and flatulence) after the procedure. So far, it has not been studied in inflammatory bowel disease patients. The study was designed to evaluate discomfort after the carbon dioxide insufflation colonoscopy in comparison to standard air insufflation colonoscopy.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

The Use of CO2 in Routine-Colonoscopy

NCT03141697

Colonoscopy

COMPLETED NA

Water-aided Colonoscopy in Inflammatory Bowel Disease Patients

NCT01933867

Inflammatory Bowel Disease

COMPLETED NA

The Application of CO2 Insufflations in Routine Colonoscopy Examination for Duration in Toilet After Examination Compared With Air Insufflations

NCT01807312

Carbon Dioxide Insufflation

COMPLETED NA

Impact of Carbon Dioxide Insufflation and Water Exchange on Post-Colonoscopy Outcomes

NCT02409979

Abdominal Pain

COMPLETED NA

Application of CO2 Insufflations in Colonoscopy Randomized Trial

NCT00745927

Colorectal Neoplasm Colorectal Cancer

UNKNOWN NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Carbon dioxide insufflation during colonoscopy significantly reduces discomfort (pain, bloating and flatulence) during up to 24 hours after the procedure. So far, it has not been studied in inflammatory bowel disease patients who represent specific patient population indicated for colonoscopy. They are characterized by younger age, structural changes of the colon including intestinal resections and need for repeated and frequently difficult procedures.The study was designed to evaluate discomfort during 24 hours after the carbon dioxide insufflation colonoscopy in comparison to standard air insufflation colonoscopy.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Colonoscopy Carbon Dioxide Inflammatory Bowel Disease

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

DIAGNOSTIC

Blinding Strategy

TRIPLE

Participants Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Carbon dioxide insufflation colonoscopy (CO2)

Carbon dioxide during both insertion and withdrawal phase of the colonoscopy.

Group Type EXPERIMENTAL

Carbon dioxide insufflation

Intervention Type PROCEDURE

Carbon dioxide insufflation during diagnostic colonoscopy

Air insufflation colonoscopy (AI)

Air insufflation during both insertion and withdrawal phase of the colonoscopy.

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.